Lucid Diagnostics (LUCD) Return on Capital Employed Growth (1y) (2022 - 2026)
Lucid Diagnostics (LUCD) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 216.00 |
| 10 | Lucid Diagnostics | 175.80 Mn | 142.40 Mn | 55,000.00 | 19,681.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19,681.00 |
| Mar 31, 2026 | -161,728.00 |
| Dec 31, 2025 | 119,801.00 |
| Sep 30, 2025 | 7,660.00 |
| Jun 30, 2025 | -49,956.00 |
| Mar 31, 2025 | 145,619.00 |
| Dec 31, 2024 | 407,063.00 |
| Sep 30, 2024 | 36,066.00 |
| Jun 30, 2024 | 2,834.00 |
| Mar 31, 2024 | -12,976.00 |
| Dec 31, 2023 | -533,260.00 |
| Sep 30, 2023 | -51,744.00 |
| Jun 30, 2023 | -19,156.00 |
| Mar 31, 2023 | -25,694.00 |
| Dec 31, 2022 | -10,622.00 |